	2 4 6 8 10 12
International Journal of Molecular Sciences	International Journal of Molecular Sciences, 12, 4.38% International Journal of Molecular Sciences 12 публикаций, 4.38%
ACS Nano	ACS Nano, 7, 2.55% ACS Nano 7 публикаций, 2.55%
Cancers	Cancers, 6, 2.19% Cancers 6 публикаций, 2.19%
Advanced Materials	Advanced Materials, 5, 1.82% Advanced Materials 5 публикаций, 1.82%
Proceedings of the National Academy of Sciences of the United States of America	Proceedings of the National Academy of Sciences of the United States of America, 5, 1.82% Proceedings of the National Academy of Sciences of the United States of America 5 публикаций, 1.82%
Pharmaceutics	Pharmaceutics, 4, 1.46% Pharmaceutics 4 публикации, 1.46%
Nanomaterials	Nanomaterials, 4, 1.46% Nanomaterials 4 публикации, 1.46%
Journal of Controlled Release	Journal of Controlled Release, 4, 1.46% Journal of Controlled Release 4 публикации, 1.46%
Advanced Drug Delivery Reviews	Advanced Drug Delivery Reviews, 4, 1.46% Advanced Drug Delivery Reviews 4 публикации, 1.46%
Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology	Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology, 4, 1.46% Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology 4 публикации, 1.46%
Journal of the American Chemical Society	Journal of the American Chemical Society, 4, 1.46% Journal of the American Chemical Society 4 публикации, 1.46%
ACS Applied Bio Materials	ACS Applied Bio Materials, 4, 1.46% ACS Applied Bio Materials 4 публикации, 1.46%
Angewandte Chemie	Angewandte Chemie, 3, 1.09% Angewandte Chemie 3 публикации, 1.09%
Angewandte Chemie - International Edition	Angewandte Chemie - International Edition, 3, 1.09% Angewandte Chemie - International Edition 3 публикации, 1.09%
Journal of Experimental and Clinical Cancer Research	Journal of Experimental and Clinical Cancer Research, 3, 1.09% Journal of Experimental and Clinical Cancer Research 3 публикации, 1.09%
Journal of Personalized Medicine	Journal of Personalized Medicine, 3, 1.09% Journal of Personalized Medicine 3 публикации, 1.09%
Drug Delivery and Translational Research	Drug Delivery and Translational Research, 3, 1.09% Drug Delivery and Translational Research 3 публикации, 1.09%
Biomedicine and Pharmacotherapy	Biomedicine and Pharmacotherapy, 3, 1.09% Biomedicine and Pharmacotherapy 3 публикации, 1.09%
Signal Transduction and Targeted Therapy	Signal Transduction and Targeted Therapy, 3, 1.09% Signal Transduction and Targeted Therapy 3 публикации, 1.09%
Nanoscale	Nanoscale, 3, 1.09% Nanoscale 3 публикации, 1.09%
Materials Today Bio	Materials Today Bio, 3, 1.09% Materials Today Bio 3 публикации, 1.09%
Molecular Pharmaceutics	Molecular Pharmaceutics, 3, 1.09% Molecular Pharmaceutics 3 публикации, 1.09%
Small	Small, 3, 1.09% Small 3 публикации, 1.09%
Coordination Chemistry Reviews	Coordination Chemistry Reviews, 3, 1.09% Coordination Chemistry Reviews 3 публикации, 1.09%
Bioengineering & Translational Medicine	Bioengineering & Translational Medicine, 2, 0.73% Bioengineering & Translational Medicine 2 публикации, 0.73%
Technology in Cancer Research and Treatment	Technology in Cancer Research and Treatment, 2, 0.73% Technology in Cancer Research and Treatment 2 публикации, 0.73%
Molecules	Molecules, 2, 0.73% Molecules 2 публикации, 0.73%
Biomolecules	Biomolecules, 2, 0.73% Biomolecules 2 публикации, 0.73%
Biomedicines	Biomedicines, 2, 0.73% Biomedicines 2 публикации, 0.73%
	2 4 6 8 10 12

Издатели

	10 20 30 40 50 60 70
Elsevier	Elsevier, 64, 23.36% Elsevier 64 публикации, 23.36%
MDPI	MDPI, 44, 16.06% MDPI 44 публикации, 16.06%
Springer Nature	Springer Nature, 40, 14.6% Springer Nature 40 публикаций, 14.6%
Wiley	Wiley, 37, 13.5% Wiley 37 публикаций, 13.5%
American Chemical Society (ACS)	American Chemical Society (ACS), 28, 10.22% American Chemical Society (ACS) 28 публикаций, 10.22%
Taylor & Francis	Taylor & Francis, 11, 4.01% Taylor & Francis 11 публикаций, 4.01%
Royal Society of Chemistry (RSC)	Royal Society of Chemistry (RSC), 11, 4.01% Royal Society of Chemistry (RSC) 11 публикаций, 4.01%
Frontiers Media S.A.	Frontiers Media S.A., 10, 3.65% Frontiers Media S.A. 10 публикаций, 3.65%
Proceedings of the National Academy of Sciences (PNAS)	Proceedings of the National Academy of Sciences (PNAS), 5, 1.82% Proceedings of the National Academy of Sciences (PNAS) 5 публикаций, 1.82%
Cold Spring Harbor Laboratory	Cold Spring Harbor Laboratory, 4, 1.46% Cold Spring Harbor Laboratory 4 публикации, 1.46%
SAGE	SAGE, 3, 1.09% SAGE 3 публикации, 1.09%
Spandidos Publications	Spandidos Publications, 2, 0.73% Spandidos Publications 2 публикации, 0.73%
Bentham Science Publishers Ltd.	Bentham Science Publishers Ltd., 2, 0.73% Bentham Science Publishers Ltd. 2 публикации, 0.73%
Neoplasia Press	Neoplasia Press, 1, 0.36% Neoplasia Press 1 публикация, 0.36%
Hindawi Limited	Hindawi Limited, 1, 0.36% Hindawi Limited 1 публикация, 0.36%
Annual Reviews	Annual Reviews, 1, 0.36% Annual Reviews 1 публикация, 0.36%
Xi'an Jiaotong University	Xi'an Jiaotong University, 1, 0.36% Xi'an Jiaotong University 1 публикация, 0.36%
SCEEMP	SCEEMP, 1, 0.36% SCEEMP 1 публикация, 0.36%
Walter de Gruyter	Walter de Gruyter, 1, 0.36% Walter de Gruyter 1 публикация, 0.36%
Radiation Research Society	Radiation Research Society, 1, 0.36% Radiation Research Society 1 публикация, 0.36%
Science in China Press	Science in China Press, 1, 0.36% Science in China Press 1 публикация, 0.36%
Oxford University Press	Oxford University Press, 1, 0.36% Oxford University Press 1 публикация, 0.36%
Acta Naturae Ltd	Acta Naturae Ltd, 1, 0.36% Acta Naturae Ltd 1 публикация, 0.36%
American Association for the Advancement of Science (AAAS)	American Association for the Advancement of Science (AAAS), 1, 0.36% American Association for the Advancement of Science (AAAS) 1 публикация, 0.36%
	10 20 30 40 50 60 70

Мы не учитываем публикации, у которых нет DOI.
Статистика публикаций обновляется еженедельно.

Вы ученый?

Создайте профиль, чтобы получать персональные рекомендации коллег, конференций и новых статей.

Войти с ORCID

Метрики

274

Цитировать

ГОСТ |

Цитировать

ГОСТ Скопировать

Dunbar E. et al. A first-in-human phase 0 clinical study of RNA interference–based spherical nucleic acids in patients with recurrent glioblastoma // Science Translational Medicine. 2021. Vol. 13. No. 584.

ГОСТ со всеми авторами (до 50) Скопировать

Dunbar E., Ko C. H., Paunesku T., Dixit K. S., Sonabend A. M., Bloch O., Tate M., Schwartz M., Zuckerman L., Lezon R., Lukas R. V., Jovanovic B., Mccortney K., Colman H., Chen S., Lai B., Antipova O., Deng J., Li L., Tommasini-Ghelfi S., Hurley L., Unruh D., Sharma N. V., Kandpal M., Kouri F. M., Davuluri R. V., Brat D. J., Muzzio M., Glass M., Vijayakumar V., Heidel J., Giles F., Adams A. K., James C. D., WOLOSCHAK G. E., Horbinski C., Stegh A. H. A first-in-human phase 0 clinical study of RNA interference–based spherical nucleic acids in patients with recurrent glioblastoma // Science Translational Medicine. 2021. Vol. 13. No. 584.

RIS |

Цитировать

RIS Скопировать

TY - JOUR

DO - 10.1126/scitranslmed.abb3945

UR - https://doi.org/10.1126/scitranslmed.abb3945

TI - A first-in-human phase 0 clinical study of RNA interference–based spherical nucleic acids in patients with recurrent glioblastoma

T2 - Science Translational Medicine

AU - Dunbar, Erin

AU - Ko, Caroline H

AU - Paunesku, T.

AU - Dixit, Karan S.

AU - Sonabend, Adam M.

AU - Bloch, Orin

AU - Tate, Matthew

AU - Schwartz, Margaret

AU - Zuckerman, Laura

AU - Lezon, Ray

AU - Lukas, Rimas V.

AU - Jovanovic, Borko

AU - Mccortney, Kathleen

AU - Colman, Howard

AU - Chen, Si

AU - Lai, Barry

AU - Antipova, Olga

AU - Deng, Junjing

AU - Li, Luxi

AU - Tommasini-Ghelfi, Serena

AU - Hurley, Lisa

AU - Unruh, Dusten

AU - Sharma, Nitya V

AU - Kandpal, Manoj

AU - Kouri, Fotini M.

AU - Davuluri, Ramana V.

AU - Brat, Daniel J.

AU - Muzzio, Miguel

AU - Glass, Mitchell

AU - Vijayakumar, Vinod

AU - Heidel, Jeremy

AU - Giles, F.J.

AU - Adams, Ann K

AU - James, C. David

AU - WOLOSCHAK, GAYLE E.

AU - Horbinski, Craig

AU - Stegh, Alexander H.

PY - 2021

DA - 2021/03/10

PB - American Association for the Advancement of Science (AAAS)

IS - 584

VL - 13

PMID - 33692132

SN - 1946-6234

SN - 1946-6242

ER -

BibTex

Цитировать

BibTex (до 50 авторов) Скопировать

@article{2021_Dunbar,

author = {Erin Dunbar and Caroline H Ko and T. Paunesku and Karan S. Dixit and Adam M. Sonabend and Orin Bloch and Matthew Tate and Margaret Schwartz and Laura Zuckerman and Ray Lezon and Rimas V. Lukas and Borko Jovanovic and Kathleen Mccortney and Howard Colman and Si Chen and Barry Lai and Olga Antipova and Junjing Deng and Luxi Li and Serena Tommasini-Ghelfi and Lisa Hurley and Dusten Unruh and Nitya V Sharma and Manoj Kandpal and Fotini M. Kouri and Ramana V. Davuluri and Daniel J. Brat and Miguel Muzzio and Mitchell Glass and Vinod Vijayakumar and Jeremy Heidel and F.J. Giles and Ann K Adams and C. David James and GAYLE E. WOLOSCHAK and Craig Horbinski and Alexander H. Stegh},

title = {A first-in-human phase 0 clinical study of RNA interference–based spherical nucleic acids in patients with recurrent glioblastoma},

journal = {Science Translational Medicine},

year = {2021},

volume = {13},

publisher = {American Association for the Advancement of Science (AAAS)},

month = {mar},

url = {https://doi.org/10.1126/scitranslmed.abb3945},

number = {584},

doi = {10.1126/scitranslmed.abb3945}

}

Издатель

American Association for the Advancement of Science (AAAS)

Журнал

Science Translational Medicine

scimago Q1

wos Q1

БС1

SJR

6.722

CiteScore

27.9

Impact factor

14.6

ISSN

19466234 (Print)

19466242 (Electronic)